Skip to main content

Advertisement

SpringerLink
Log in

Cataract Surgery Considerations for Diabetic Patients

  • Microvascular Complications—Retinopathy (R Channa, Section Editor)
  • Published:
Current Diabetes Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

Given the epidemiology and demographic trends of diabetes mellitus and cataracts, ophthalmologists are likely to encounter patients with both comorbidities at an increasing frequency. Patients with diabetes represent a higher risk population than healthy patients for cataract surgery. In this review, we discuss key risks and risk-mitigation practices when performing cataract surgery on these patients.

Recent Findings

Patients with diabetes continue to represent a high-risk surgical population: Nagar et al. suggest a dose-dependent relationship may exist between number of intravitreal injections and likelihood of posterior capsular rupture. However, novel treatments are improving outcomes for patients with diabetes. Several studies have reported intracameral phenylephrine/ketorolac may reduce the incidence of post-operative cystoid macular edema while others have discussed the efficacy of pre-treatment and post-treatment with intravitreal bevacizumab on improving cataract surgery outcomes in patients with diabetic retinopathy.

Summary

Pre-operatively, ophthalmologists should perform an enhanced evaluation, consider timing and lens selection decisions, and complete any appropriate pre-operative treatment. Peri-operatively, surgeons should be aware of pupillary dilation adjustments, combination surgery options, and potential complications. Post-operatively, clinicians should address pseudophakic cystoid macular edema, diabetic macular edema, diabetic retinopathy, and posterior capsular opacification.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Allen D, Vasavada A. Cataract and surgery for cataract. BMJ. 2006;333:128–132. http://www.v2020.org/main_page.asp.

  2. Hashemi H, Pakzad R, Yekta A, et al. Global and regional prevalence of age-related cataract: a comprehensive systematic review and meta-analysis. Eye (Basingstoke). 2020;34(8):1357–70. https://doi.org/10.1038/s41433-020-0806-3.

    Article  Google Scholar 

  3. Bourne RRA, Steinmetz JD, Saylan M, et al. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the right to sight: an analysis for the global burden of disease study. Lancet Glob Health. 2021;9(2):e144–60. https://doi.org/10.1016/S2214-109X(20)30489-7.

    Article  Google Scholar 

  4. Kelly E, Wen Q, Haddad D, O’Banion J. Effects of an aging population and racial demographics on eye disease prevalence: projections for Georgia through 2050. Am J Ophthalmol. 2020;210:35–40. https://doi.org/10.1016/j.ajo.2019.10.028.

    Article  PubMed  Google Scholar 

  5. Varma R, Vajaranant TS, Burkemper B, et al. Visual impairment and blindness in adults in the United States. JAMA Ophthalmol. 2016;134(7):802–9. https://doi.org/10.1001/jamaophthalmol.2016.1284.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Dowler JGF, Hykin PG, Hamilton AMP. Phacoemulsification versus extracapsular cataract extraction in patients with diabetes. Vol 107.; 2000.

  7. Haddad NMN, Sun JK, Abujaber S, Schlossman DK, Silva PS. Cataract surgery and its complications in diabetic patients. Semin Ophthalmol. 2014;29(5–6):329–37. https://doi.org/10.3109/08820538.2014.959197.

    Article  PubMed  Google Scholar 

  8. Pershing S, Morrison DE, Hernandez-Boussard T. Cataract surgery complications and revisit rates among three states. Am J Ophthalmol. 2016;171:130–8. https://doi.org/10.1016/j.ajo.2016.08.036.

    Article  PubMed  Google Scholar 

  9. Peterson SR, Silva PA, Murtha TJ, Sun JK. Cataract surgery in patients with diabetes: management strategies. Semin Ophthalmol. 2018;33(1):75–82. https://doi.org/10.1080/08820538.2017.1353817.

    Article  PubMed  Google Scholar 

  10. Hashim Z, Zarina S. Advanced glycation end products in diabetic and non-diabetic human subjects suffering from cataract. Age. 2011;33(3):377–84. https://doi.org/10.1007/s11357-010-9177-1.

    Article  CAS  PubMed  Google Scholar 

  11. Obrosova IG, Chung SSM, Kador PF. Diabetic cataracts: mechanisms and management. Diabetes Metab Res Rev. 2010;26(3):172–80. https://doi.org/10.1002/dmrr.1075.

    Article  CAS  PubMed  Google Scholar 

  12. Obrosova IG, Fathallah L, Lang HJ. Interaction between osmotic and oxidative stress in diabetic precataractous lens: studies with a sorbitol dehydrogenase inhibitor. Biochem Pharmacol. 1999;58(12):1945–54. https://doi.org/10.1016/S0006-2952(99)00315-9.

    Article  CAS  PubMed  Google Scholar 

  13. Obrosova IG. Increased sorbitol pathway activity generates oxidative stressin tissue sites for diabetic complications. Antioxid Redox Signal. 2005;7(11):1543–52.

    Article  CAS  Google Scholar 

  14. Sayin N, Kara N, Pekel G. Ocular complications of diabetes mellitus. World J Diabetes. 2015;6(1):92. https://doi.org/10.4239/wjd.v6.i1.92.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Skarbez K, Priestley Y, Hoepf M, Koevary SB. Comprehensive review of the effects of diabetes on ocular health. Expert Rev Ophthalmol. 2010;5(4):557–77. https://doi.org/10.1586/eop.10.44.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Klein BEK, Klein R, Moss SE. Prevalence of cataracts in a population-based study of persons with diabetes mellitus. Ophthalmology. 1985;92(9). https://doi.org/10.1016/S0161-6420(85)33877-0

  17. Cristina Leske M, Wu S-Y, Hennis A, Connell SAM, Hyman L, Schachat A. Diabetes, hypertension, and central obesity as cataract risk factors in a black population the Barbados eyes. Ophthalmology. 1999;106(1):35–41.

    Article  Google Scholar 

  18. Klein BEK, Klein R, Moss SE. Incidence of cataract surgery in the Wisconsin Epidemiologie Study of Diabetic Retinopathy. Am J Ophthalmol. 1995;119:295–300.

    Article  CAS  Google Scholar 

  19. Kiziltoprak H, Tekin K, Inanc M, Goker YS. Cataract in diabetes mellitus. World J Diabetes. 2019;10(3):140–53. https://doi.org/10.4239/wjd.v10.i3.140.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Rowe N, Mitchell P, Cumming R, Wans J. Diabetes, fasting blood glucose and age-related cataract: the Blue Mountains Eye Study. Ophthalmic Epidemiol. 2000;7(2):103–14.

    Article  CAS  Google Scholar 

  21. Negahban K, Chern K. Cataracts associated with systemic disorders and syndromes. Curr Opin Ophthalmol. 2002;13(6). https://doi.org/10.1097/00055735-200212000-00013

  22. Srinivasan S, Raman R, Swaminathan G, Ganesan S, Kulothungan V, Sharma T. Incidence, progression, and risk factors for cataract in type 2 diabetes. Invest Ophthalmol Vis Sci. 2017;58(13):5921–9. https://doi.org/10.1167/iovs.17-22264.

    Article  CAS  PubMed  Google Scholar 

  23. Klein BEK, Klein R, Lee KE. Diabetes, cardiovascular disease, selected cardiovascular disease risk factors, and the5-year incidence of age-related cataract and progression of lens opacities: the Beaver Dam Eye Study. Am J Ophthalmol. 1998;126:782–90.

    Article  CAS  Google Scholar 

  24. Li L, Wan XH, Zhao GH. Meta-analysis of the risk of cataract in type 2 diabetes. BMC Ophthalmol. 2014;14(1). https://doi.org/10.1186/1471-2415-14-94

  25. Cohen SR, Gardner TW. Diabetic retinopathy and diabetic macular edema. Dev Ophthalmol. 2015;55:137–46. https://doi.org/10.1159/000438970.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Liu X, Shun GY, Sheng XY. Changes of tear film and tear secretion after phacoemulsification in diabetic patients. J Zhejiang Univ Sci B. 2008;9(4):324–8. https://doi.org/10.1631/jzus.B0710359.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Jiang D, Xiao X, Fu T, Mashaghi A, Liu Q, Hong J. Transient tear film dysfunction after cataract surgery in diabetic patients. PLoS ONE. 2016;11(1). https://doi.org/10.1371/journal.pone.0146752.

  28. Zhang X, Zhao L, Deng S, Sun X, Wang N. Dry eye syndrome in patients with diabetes mellitus: prevalence, etiology, and clinical characteristics. J Ophthalmol. 2016;2016. https://doi.org/10.1155/2016/8201053.

  29. Manaviat MR, Rashidi M, Afkhami-Ardekani M, Shoja MR. Prevalence of dry eye syndrome and diabetic retinopathy in type 2 diabetic patients. BMC Ophthalmol. 2008;8. https://doi.org/10.1186/1471-2415-8-10.

  30. Morikubo S, Takamura Y, Kubo E, Tsuzuki S, Akagi Y. Corneal changes after small-incision cataract surgery in patients with diabetes mellitus. Arch Ophthalmol. 2004;122:966–969. https://jamanetwork.com/.

  31. Hugod M, Storr-Paulsen A, Norregaard JC, Nicolini J, Larsen AB, Thulesen J. Corneal endothelial cell changes associated with cataract surgery in patients with type 2 diabetes mellitus. Cornea. 2011;30(7):749–753. http://www.corneajrnl.com.

  32. Lee JS, Lee JE, Choi HY, Oum BS, Byung MC. Corneal endothelial cell change after phacoemulsification relative to the severity of diabetic retinopathy. J Cataract Refract Surg. 2005;31(4):742–9. https://doi.org/10.1016/j.jcrs.2004.09.035.

    Article  PubMed  Google Scholar 

  33. Yang R, Sha Z, Zeng M, Tan Y, Zheng Y, Fan F. The influence of phacoemulsification on corneal endothelial cells at varying blood glucose levels. Eye Sci. 2011;26(2):91–5.

    CAS  PubMed  Google Scholar 

  34. Sudhir RR, Raman R, Sharma T. Changes in the corneal endothelial cell density and morphology in patients with type 2 diabetes mellitus: a population-based study, Sankara Nethralaya Diabetic Retinopathy And Molecular Genetics Study (SN-DREAMS, Report 23). Cornea. 2012;31:1119–1122. http://www.corneajrnl.com.

  35. Urban B, Raczyńska D, Bakunowicz-ŁAzarczyk A, Raczyńska K, Krȩtowska M. Evaluation of corneal endothelium in children and adolescents with type 1 diabetes mellitus. Mediat Inflamm. 2013;2013. https://doi.org/10.1155/2013/913754.

  36. Storr-Paulsen A, Singh A, Jeppesen H, Norregaard JC, Thulesen J. Corneal endothelial morphology and central thickness in patients with type II diabetes mellitus. Acta Ophthalmol. 2014;92(2):158–60. https://doi.org/10.1111/aos.12064.

    Article  PubMed  Google Scholar 

  37. Goldstein AS, Janson BJ, Skeie JM, Ling JJ, Greiner MA. The effects of diabetes mellitus on the corneal endothelium: a review. Surv Ophthalmol. 2020;65(4):438–50. https://doi.org/10.1016/j.survophthal.2019.12.009.

    Article  PubMed  Google Scholar 

  38. Misra SL, Goh YW, Patel D v, Riley AF, McGhee CN. Corneal microstructural changes in nerve fiber, endothelial and epithelial density after cataract surgery in patients with diabetes mellitus. Cornea. 2015;34:177–181. http://www.corneajrnl.com.

  39. Ghasemi H, Gharebaghi R, Heidary F. Diabetes as a possible predisposer for blepharitis. Can J Ophthalmol. 2008;43(4):485–485.

    Article  Google Scholar 

  40. Kruse A, Thomsen R, Hundborg H, Knudsen L, Sorensen H, Schonheyder H. Diabetes and risk of acute infectious conjunctivitis—a population-based case-control study. Diabet Med. 2006;23:393–7.

    Article  CAS  Google Scholar 

  41. Karimsab D, Razak S. Study of aerobic bacterial conjunctival flora in patients with diabetes mellitus. Nepal J Ophthalmol. 2013;5(9):28–32.

    Article  CAS  Google Scholar 

  42. Fernández-Rubio ME, Rebolledo-Lara L, Martinez-García M, Alarcón-Tomás M, Cortés-Valdés C. The conjunctival bacterial pattern of diabetics undergoing cataract surgery. Eye. 2010;24(5):825–34. https://doi.org/10.1038/eye.2009.218.

    Article  PubMed  Google Scholar 

  43. Scott IU, Flynn HW, Feuer W. Endophthalmitis after secondary intraocular lens implantation a case-control study. Ophthalmology. 1995;102:1925–31.

    Article  CAS  Google Scholar 

  44. El-Mollayess GM, Saadeh JS, Salti HI. Exogenous endophthalmitis in diabetic patients: a systemic review. ISRN Ophthalmol. 2012;2012:1–7. https://doi.org/10.5402/2012/456209.

    Article  Google Scholar 

  45. Casqueiro J, Casqueiro J, Alves C. Infections in patients with diabetes mellitus: a review of pathogenesis. Indian J Endocrinol Metab. 2012;16(7):27. https://doi.org/10.4103/2230-8210.94253.

    Article  Google Scholar 

  46. Kattan H, Flynn H Jr, Pflugfelder S, Robertson C, Forster R. Nosocomial endophthalmitis survey. Current incidence of infection after intraocular surgery. Ophthalmology. 1991;98(2):227–38.

    Article  CAS  Google Scholar 

  47. Doft BH, Wisniewski SR, Kelsey SF, Groer-Fitzgerald S. Diabetes and postcataract extraction endophthalmitis. Curr Opin Ophthalmol. 2002;13(3). https://doi.org/10.1097/00055735-200206000-00003.

  48. Grzybowski A, Kanclerz P, Huerva V, Ascaso FJ, Tuuminen R. Diabetes and phacoemulsification cataract surgery: difficulties, risks and potential complications. J Clin Med. 2019;8(5):716. https://doi.org/10.3390/jcm8050716.

    Article  CAS  PubMed Central  Google Scholar 

  49. Sun Y, Liang Y, Zhou P, et al. Anti-VEGF treatment is the key strategy for neovascular glaucoma management in the short term. BMC Ophthalmol. 2016;16(1). https://doi.org/10.1186/s12886-016-0327-9.

  50. Okamoto F, Sone H, Nonoyama T, Hommura S. Refractive changes in diabetic patients during intensive glycaemic control. Vol 84.; 2000. http://www.bjophthalmol.com.

  51. Pollack A, Leiba H, Bukelman A, Oliver M. Cystoid macular oedema following cataract extraction in patients with diabetes. Vol 76.; 1992.

  52. Schatz H, Atienza D, McDonald HR, Johnson RN. Severe diabetic retinopathy after cataract surgery. Am J Ophthalmol. 1994;117(3). https://doi.org/10.1016/S0002-9394(14)73138-1.

  53. Chew EY, Benson WE, Remaley NA, et al. Results after lens extraction in patients with diabetic retinopathy early treatment diabetic retinopathy study report number 25. Vol 117.; 1999. https://jamanetwork.com/.

  54. Shalchi Z, Okada M, Whiting C, Hamilton R. Risk of posterior capsule rupture during cataract surgery in eyes with previous intravitreal injections. Am J Ophthalmol. 2017;177:77–80. https://doi.org/10.1016/j.ajo.2017.02.006.

    Article  PubMed  Google Scholar 

  55. Adnan MS, Efron N, Edwards K, et al. Biometry of eyes in type 1 diabetes. Biomed Opt Express. 2015;6(3):702. https://doi.org/10.1364/boe.6.000702.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Larsson L-I, Bourne WM, Pach JM, Brubaker RF. Structure and function of the corneal endothelium in diabetes mellitus type I and type II. Arch Ophthalmol. 1996;114:9–14. https://jamanetwork.com/.

  57. Sonmez B, Bozkurt B, Atmaca A, Irkec M, Orhan M, Aslan U. Effect of glycemic control on refractive changes in diabetic patients with hyperglycemia. Cornea. 2005;24:531–7.

    Article  Google Scholar 

  58. Mayer CF, Ardjomand N, Wackernagel W, Velikay-Parel M. Misleading axial length measurements with the IOLMaster due to a dense posterior vitreous surface membrane and a macular edema in a diabetic patient. Graefe’s Arch Clin Exp Ophthalmol. 2013;251(1):387–9. https://doi.org/10.1007/s00417-011-1852-0.

    Article  Google Scholar 

  59. Attas-Fox L, Zadok D, Gerber Y, et al. Axial length measurement in eyes with diabetic macular edema A-scan ultrasound versus IOLMaster. Ophthalmology. 2007;114(8):1499–504. https://doi.org/10.1016/j.ophtha.2006.10.053.

    Article  PubMed  Google Scholar 

  60. Shah AS, Chen SH. Cataract surgery and diabetes. Curr Opin Ophthalmol. 2010;21(1):4–9. https://doi.org/10.1097/ICU.0b013e328333e9c1.

    Article  PubMed  Google Scholar 

  61. The DCCT/EDIC Research Group. Intensive diabetes therapy and ocular surgery in type 1 diabetes. N Engl J Med. 2015;372(18):1722–33. https://doi.org/10.1056/NEJMoa1409463.

    Article  PubMed Central  Google Scholar 

  62. Ylinen P, Laine I, Lindholm J-M, Tuuminen R. Poor glycemic control as a risk factor for pseudophakic cystoid macular edema in patients with diabetes. J Cataract Refract Surg. 2017;43(11). https://doi.org/10.1016/j.jcrs.2017.07.035.

  63. Woo JH, di Ng W, Salah MM, Neelam K, Au Eong KG, Kumar CM. Perioperative glycaemic control in diabetic patients undergoing cataract surgery under local anaesthesia: a survey of practices of singapore ophthalmologists and anaesthesiologists. Singapore Med J. 2016;57(2):64–8. https://doi.org/10.11622/smedj.2016029.

    Article  PubMed  PubMed Central  Google Scholar 

  64. Nathan DM, Kuenen J, Borg R, et al. Translating the A1C assay into estimated average glucose values. Diabetes Care. 2009;31:1–6. https://doi.org/10.2337/dc07-0545.

    Article  CAS  Google Scholar 

  65. Suto C, Hori S, Kato S, Muraoka K, Kitano S. Effect of perioperative glycemic control in progression of diabetic retinopathy and maculopathy. Arch Ophthalmol. 2006;124:38–45. https://jamanetwork.com/.

  66. Hong T, Mitchell P, de Loryn T, Rochtchina E, Cugati S, Wang JJ. Development and progression of diabetic retinopathy 12 months after phacoemulsification cataract surgery. Ophthalmology. 2009;116(8):1510–4. https://doi.org/10.1016/j.ophtha.2009.03.003.

    Article  PubMed  Google Scholar 

  67. The Diabetic Retinopathy Clinical Research Network, Elman MJ, Aiello LP, et al. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology. 2010;117(6). https://doi.org/10.1016/j.ophtha.2010.02.031.

  68. Early Treatment Diabetic Retinopathy Study Research Group. Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema. Ophthalmology. 1987;94(7). https://doi.org/10.1016/S0161-6420(87)33527-4.

  69. Medić A, Jukić T, Matas A, Vukojević K, Sapunar A, Znaor L. Effect of preoperative topical diclofenac on intraocular interleukin-12 concentration and macular edema after cataract surgery in patients with diabetic retinopathy: a randomized controlled trial. Croat Med J. 2017;58(1):49–55. https://doi.org/10.3325/cmj.2017.58.49.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  70. Yüksel B, Karti Ö, Kusbeci T. Topical nepafenac for prevention of post-cataract surgery macular edema in diabetic patients: patient selection and perspectives. Clin Ophthalmol. 2017;11:2183–90. https://doi.org/10.2147/OPTH.S132810.

    Article  PubMed  PubMed Central  Google Scholar 

  71. Tu Y, Fay C, Guo S, Zarbin M, Marcus E, Bhagat N. Ranibizumab in patients with dense cataract and proliferative diabetic retinopathy with rubeosis. Oman J Ophthalmol. 2012;5(3). https://doi.org/10.4103/0974-620X.106099.

  72. Rabin RL, Rabin AR, Zhang AD, Burney EN, Rhee DJ. Co-management of cataract and glaucoma in the era of minimally invasive glaucoma surgery. Curr Opin Ophthalmol. 2018;29(1). https://doi.org/10.1097/ICU.0000000000000444.

  73. Ogata-Iwao M, Inatani M, Takihara Y, Inoue T, Iwao K, Tanihara H. A prospective comparison between trabeculectomy with mitomycin C and phacotrabeculectomy with mitomycin C. Acta Ophthalmol. 2013;91(6). https://doi.org/10.1111/aos.12133.

  74. Lee D-H, Seo Y, Joo C-K. Progressive opacification of hydrophilic acrylic intraocular lenses in diabetic patients. Vol 28.; 2002.

  75. Kugelberg M, Wejde G, Jayaram H, Zetterström C. Posterior capsule opacification after implantation of a hydrophilic or a hydrophobic acrylic intraocular lens. One-year follow-up. J Cataract Refract Surg. 2006;32(10):1627–31. https://doi.org/10.1016/j.jcrs.2006.05.011.

    Article  PubMed  Google Scholar 

  76. Kim CJ, Choi SK. Analysis of aqueous humor calcium and phosphate from cataract eyes with and without diabetes mellitus. Vol 21.; 2007.

  77. Vasavada AR, Raj SM, Shah A, Shah G, Vasavada V, Vasavada V. Comparison of posterior capsule opacification with hydrophobic acrylic and hydrophilic acrylic intraocular lenses. J Cataract Refract Surg. 2011;37(6). https://doi.org/10.1016/j.jcrs.2010.12.060.

  78. Eaton AM, Jaffe G, Mccuen Ii W, Mincey G. Condensation on the posterior surface of silicone intraocular lenses during fluid-air exchange. Ophthalmology. 1995;102:733–6.

    Article  CAS  Google Scholar 

  79. Nishi O, Nishi K, Osakabe Y. Effect of intraocular lenses on preventing posterior capsule opacification: design versus material. J Cataract Refract Surg. 2004;30(10):2170–6. https://doi.org/10.1016/j.jcrs.2004.05.022.

    Article  PubMed  Google Scholar 

  80. Braga-Mele R, Chang D, Dewey S, et al. Multifocal intraocular lenses: relative indications and contraindications for implantation. J Cataract Refract Surg. 2014;40(2). https://doi.org/10.1016/j.jcrs.2013.12.011.

  81. Grzybowski A, Kanclerz P. Methods for achieving adequate pupil size in cataract surgery. Curr Opin Ophthalmol. 2020;31(1):33–42. https://doi.org/10.1097/ICU.0000000000000634.

    Article  PubMed  Google Scholar 

  82. Inan U, Ozturk F, Ermis S. Pharmacologic pupil dilation in diabetic patients. Retina. 2003;23(2). https://doi.org/10.1097/00006982-200304000-00024.

  83. Hreidarsson AB. Pupil motility in long-term diabetes. Vol 17.; 1979.

  84. Henricsson M, Heijl A, Janzon L. Diabetic retinopathy before and after cataract surgery. Vol 80.; 1996.

  85. Cahill M, Eustace P, de Jesus V. Pupillary autonomic denervation with increasing duration of diabetes mellitus. Vol 85.; 2001. http://www.bjophthalmol.com.

  86. Smith SA, Smith SE. Evidence for a neuropathic aetiology in the small pupil of diabetes mellitus. Vol 67.; 1983.

  87. Huber MJE, Smith SA, Smith2 SE. Mydriatic drugs for diabetic patients. Vol 69.; 1985.

  88. Suwan-Apichon O, Ratanapakorn T, Panjaphongse R, Sinawat S, Sanguansak T, Yospaiboon Y. 2.5% and 10% phenylephrine for mydriasis in diabetic patients with darkly pigmented irides. J Med Assoc Thai. 2010;93(4):467–73.

    PubMed  Google Scholar 

  89. Masket S, Belani S. Combined preoperative topical atropine sulfate 1% and intracameral nonpreserved epinephrine hydrochloride 1:2500 for management of intraoperative floppy-iris syndrome. J Cataract Refract Surg. 2007;33(4). https://doi.org/10.1016/j.jcrs.2006.10.059.

  90. Joshi RS. Phacoemulsification without preoperative mydriasis in patients with age-related cataract associated with type 2 diabetes. Clin Ophthalmol. 2016;10:2427–32. https://doi.org/10.2147/OPTH.S122107.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  91. • Visco DM, Bedi R. Effect of intracameral phenylephrine 1.0%–ketorolac 0.3% on postoperative cystoid macular edema, iritis, pain, and photophobia after cataract surgery. J Cataract Refract Surg. 2020;46(6). https://doi.org/10.1097/j.jcrs.0000000000000193. A retrospective, 2-cohort study was performed to evaluate the efficacy of intracameral phenylephrine/ketorolac during cataract surgery on incidence of post-operative cystoid macular edema. Analysis of 2218 eyes showed intracameral phenylephrine/ketorolac and topical NSAIDs without post-operative topical steroids reduced post-operative cystoid macular edema, as well as breakthrough iritis and pain, compared to peri-operative topical steroids and NSAIDs alone.

  92. Wilczynski M, Kucharczyk M. Phacoemulsification with Malyugin ring in an eye with iridoschisis, narrow pupil, anterior and posterior synechiae: case report. Eur J Ophthalmol. 2013;23(6):909–12. https://doi.org/10.5301/ejo.5000300.

    Article  PubMed  Google Scholar 

  93. Bhattacharjee S. B-HEX pupil expander: pupil expansion redefined. Indian J Ophthalmol. 2017;65(12):1407–10. https://doi.org/10.4103/ijo.IJO_673_17.

    Article  PubMed  PubMed Central  Google Scholar 

  94. Malyugin B. Cataract surgery in small pupils. Indian J Ophthalmol. 2017;65(12):1323–8. https://doi.org/10.4103/ijo.IJO_800_17.

    Article  PubMed  PubMed Central  Google Scholar 

  95. Tian JJ, Garcia GA, Karanjia R, Lu KL. Comparison of 2 pupil expansion devices for small-pupil cataract surgery. J Cataract Refract Surg. 2016;42(8). https://doi.org/10.1016/j.jcrs.2016.07.002.

  96. Bhattacharjee S. Pupil-expansion ring implantation through a 0.9 mm incision. J Cataract Refract Surg. 2014;40(7). https://doi.org/10.1016/j.jcrs.2014.05.003.

  97. Cetinkaya A, Yilmaz G, Akova YA. Photic retinopathy after cataract surgery in diabetic patients. Retina. 2006;26(9). https://doi.org/10.1097/01.iae.0000254895.78766.af.

  98. • Nagar AM, Luis J, Kainth N, Panos GD, Mckechnie CJ, Patra S. Risk of posterior capsular rupture during phacoemulsification cataract surgery in eyes with previous intravitreal antivascular endothelial growth factor injections. J Cataract Refract Surg. 2020;46(2):204–8. https://doi.org/10.1016/j.jcrs.2019.09.004. A retrospective database study was performed to evaluate the predictive value of prior intravitreal anti-vascular endothelial growth factor injections on posterior capsular rupture during cataract surgery. Analysis of 4047 operations showed a dose-dependent relationship between number of injections and likelihood of posterior capsular rupture.

    Article  PubMed  Google Scholar 

  99. Shalchi Z, Okada M, Whiting C, Hamilton R. Risk of posterior capsule rupture during cataract surgery in eyes with previous intravitreal injections. Am J Ophthalmol. 2017;177. https://doi.org/10.1016/j.ajo.2017.02.006.

  100. Pardo-Muñoz A, Muriel-Herrero A, Abraira V, Muriel A, Muñoz-Negrete FJ, Murube J. Phacoemulsification in previously vitrectomized patients: an analysis of the surgical results in 100 eyes as well as the factors contributing to the cataract formation. Eur J Ophthalmol. 2006;16(1). https://doi.org/10.1177/112067210601600110.

  101. Cole CJ, Charteris DG. Cataract extraction after retinal detachment repair by vitrectomy : visual outcome and complications. Eye. 2009;23(6). https://doi.org/10.1038/eye.2008.255.

  102. Canan H, Sizmaz S, Altan-Yaycioǧlu R. Surgical results of combined pars plana vitrectomy and phacoemulsification for vitreous hemorrhage in PDR. Clin Ophthalmol. 2013;7:1597–601. https://doi.org/10.2147/OPTH.S47780.

    Article  PubMed  PubMed Central  Google Scholar 

  103. Murtha T, Cavallerano J. The management of diabetic eye disease in the setting of cataract surgery. Curr Opin Ophthalmol. 2007;18:13–8.

    Article  Google Scholar 

  104. Kelkar A, Kelkar J, Mehta H, Amoaku W. Cataract surgery in diabetes mellitus: a systematic review. Indian J Ophthalmol. 2018;66(10):1401–10. https://doi.org/10.4103/ijo.IJO_1158_17.

    Article  PubMed  PubMed Central  Google Scholar 

  105. Silva PS, Diala PA, Hamam RN, et al. Visual outcomes from pars plana vitrectomy versus combined pars plana vitrectomy, phacoemulsification, and intraocular lens implantation in patients with diabetes. Retina. 2014;34(10). https://doi.org/10.1097/IAE.0000000000000171.

  106. Yoon K-C, Inn S-K, Seo M-S. Changes of tear film and ocular surface in diabetes mllitus. Korean J Ophthalmol. 2004;18:168–74.

    Article  Google Scholar 

  107. Inoue K, Kato S, Ohara C, Numaga J, Amano S, Oshika T. Ocular and systemic factors relevant to diabetic keratoepitheliopathy. Cornea. 2001;20(8). https://doi.org/10.1097/00003226-200111000-00004.

  108. Saghizadeh M, Kramerov AA, Yu F shin X, Castro MG, Ljubimov A v. Normalization of wound healing and diabetic markers in organ cultured human diabetic corneas by adenoviral delivery of c-met gene. Investig Ophthalmol Vis Sci. 2010;51(4):1970–1980. https://doi.org/10.1167/iovs.09-4569.

  109. Schultz R, van Horn DL, Peters MA, Klewin KM, Schutten WH. Diabetic keratopathy. Trans Am Ophthalmol Soc. 1981;79:180–99.

    CAS  PubMed  PubMed Central  Google Scholar 

  110. Grzybowski A, Kanclerz P, Myers WG. The use of povidone-iodine in ophthalmology. Curr Opin Ophthalmol. 2018;29(1):19–32. https://doi.org/10.1097/ICU.0000000000000437.

    Article  PubMed  Google Scholar 

  111. Lee AY, Day AC, Egan C, et al. Previous intravitreal therapy is associated with increased risk of posterior capsule rupture during cataract surgery. Ophthalmology. 2016;123(6):1252–6. https://doi.org/10.1016/j.ophtha.2016.02.014.

    Article  PubMed  Google Scholar 

  112. Chu CJ, Johnston RL, Buscombe C, Sallam AB, Mohamed Q, Yang YC. Risk factors and incidence of macular edema after cataract surgery a database study of 81984 eyes. Ophthalmology. 2016;123(2):316–23. https://doi.org/10.1016/j.ophtha.2015.10.001.

    Article  PubMed  Google Scholar 

  113. Yonekawa Y, Kim IK. Pseudophakic cystoid macular edema. Curr Opin Ophthalmol. 2012;23(1):26–32. https://doi.org/10.1097/ICU.0b013e32834cd5f8.

    Article  PubMed  Google Scholar 

  114. Javadi M-A, Zarei-Ghanavati S. Cataracts and diabetes mellitus; Javadi et al. 52 Cataracts in diabetic patients: a review article. Vol 3.; 2008.

  115. Yang J, Cai L, Sun Z, et al. Risk factors for and diagnosis of pseudophakic cystoid macular edema after cataract surgery in diabetic patients. J Cataract Refract Surg. 2017;43(2). https://doi.org/10.1016/j.jcrs.2016.11.047.

  116. Holló G, Aung T, Cantor LB, Aihara M. Cystoid macular edema related to cataract surgery and topical prostaglandin analogs: mechanism, diagnosis, and management. Surv Ophthalmol. Published online 2020.https://doi.org/10.1016/j.survophthal.2020.02.004.

  117. Wielders LHP, Lambermont VA, Schouten JSAG, et al. Prevention of cystoid macular edema after cataract surgery in nondiabetic and diabetic patients: a systematic review and meta-analysis. Am J Ophthalmol. 2015;160(5):968-981.e33. https://doi.org/10.1016/j.ajo.2015.07.032.

    Article  PubMed  Google Scholar 

  118. Wielders LHP, Schouten JSAG, Nuijts RMMA. Prevention of macular edema after cataract surgery. Curr Opin Ophthalmol. 2018;29(1):48–53. https://doi.org/10.1097/ICU.0000000000000436.

    Article  PubMed  Google Scholar 

  119. Kessel L, Tendal B, Jørgensen KJ, et al. Post-cataract prevention of inflammation and macular edema by steroid and nonsteroidal anti-inflammatory eye drops: a systematic review. Ophthalmology. 2014;121(10):1915–24. https://doi.org/10.1016/j.ophtha.2014.04.035.

    Article  PubMed  Google Scholar 

  120. Singh R, Alpern L, Jaffe GJ, et al. Evaluation of nepafenac in prevention of macular edema following cataract surgery in patients with diabetic retinopathy. Clin Ophthalmol. 2012;6(1):1259–69. https://doi.org/10.2147/OPTH.S31902.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  121. Singh RP, Lehmann R, Martel J, et al. Nepafenac 0.3% after cataract surgery in patients with diabetic retinopathy: results of 2 randomized phase 3 studies. Ophthalmology. 2017;124(6):776–85. https://doi.org/10.1016/j.ophtha.2017.01.036.

    Article  PubMed  Google Scholar 

  122. Sheppard JD. Topical bromfenac for prevention and treatment of cystoid macular edema following cataract surgery: a review. Clin Ophthalmol. 2016;10:2099–111. https://doi.org/10.2147/OPTH.S86971.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  123. Boscia F, Giancipoli E, Ricci GDA, Pinna A. Management of macular oedema in diabetic patients undergoing cataract surgery. Curr Opin Ophthalmol. 2017;28(1):23–8. https://doi.org/10.1097/ICU.0000000000000328.

    Article  PubMed  Google Scholar 

  124. Lim BX, Lim CHL, Lim DK, Evans JR, Bunce C, Wormald R. Prophylactic non-steroidal anti-inflammatory drugs for the prevention of macular oedema after cataract surgery. Cochrane Database Syst Rev. 2016;2016(11). https://doi.org/10.1002/14651858.CD006683.pub3.

  125. Modjtahedi BS, Paschal JF, Batech M, Luong TQ, Fong DS. Perioperative topical nonsteroidal anti-inflammatory drugs for macular edema prophylaxis following cataract surgery. Am J Ophthalmol. 2017;176:174–82. https://doi.org/10.1016/j.ajo.2017.01.006.

    Article  CAS  PubMed  Google Scholar 

  126. Han Jv, Patel Dv, Squirrell D, McGhee CNJ. Cystoid macular oedema following cataract surgery: a review. Clin Exp Ophthalmol. 2019;47(3):346–56. https://doi.org/10.1111/ceo.13513.

    Article  PubMed  Google Scholar 

  127. Wielders LHP, Schouten JSAG, Aberle MR, et al. Treatment of cystoid macular edema after cataract surgery. J Cataract Refract Surg. 2017;43(2). https://doi.org/10.1016/j.jcrs.2016.06.041.

  128. Campochiaro PA, Han YS, Mir TA, et al. Increased frequency of topical steroids provides benefit in patients with recalcitrant postsurgical macular edema. Am J Ophthalmol. 2017;178. https://doi.org/10.1016/j.ajo.2017.03.033.

  129. Denniston AK, Chakravarthy U, Zhu H, et al. The UK Diabetic Retinopathy Electronic Medical Record (UK DR EMR) Users Group, report 2: real-world data for the impact of cataract surgery on diabetic macular oedema. Br J Ophthalmol. 2017;101(12):1673–8. https://doi.org/10.1136/bjophthalmol-2016-309838.

    Article  PubMed  Google Scholar 

  130. Dowler JGF, Sehmi KS, Hykin PG, Hamilton AMP. The Natural History of Macular Edema after Cataract Surgery in Diabetes. Vol 106.; 1999.

  131. The Diabetic Retinopathy Clinical Research Network, Baker CW, Almukhtar T, et al. Macular edema after cataract surgery in eyes without preoperative central-involved diabetic macular edema. JAMA Ophthalmol. 2013;131(7):870–9. https://doi.org/10.1001/jamaophthalmol.2013.2313.

    Article  PubMed Central  Google Scholar 

  132. Kim SJ, Equi R, Bressler NM. Analysis of macular edema after cataract surgery in patients with diabetes using optical coherence tomography. Ophthalmology. 2007;114(5):881–9. https://doi.org/10.1016/j.ophtha.2006.08.053.

    Article  PubMed  Google Scholar 

  133. Denniston AK, Lee AY, Lee CS, et al. United Kingdom Diabetic Retinopathy Electronic Medical Record (UK DR EMR) Users Group: report 4, real-world data on the impact of deprivation on the presentation of diabetic eye disease at hospital services. Br J Ophthalmol. Published online 2018. https://doi.org/10.1136/bjophthalmol-2018-312568.

  134. Diabetic Retinopathy Clinical Research Network. A phase 2 randomized clinical trial of intravitreal bevacizumab for diabetic macular edema Diabetic Retinopathy Clinical Research Network *. Vol 114.; 2007. http://aaojournal.org.

  135. Nguyen QD, Brown DM, Marcus DM, et al. Ranibizumab for diabetic macular edema: results from 2 phase iii randomized trials: RISE and RIDE. Ophthalmology. 2012;119(4):789–801. https://doi.org/10.1016/j.ophtha.2011.12.039.

    Article  PubMed  Google Scholar 

  136. Nguyen QD, Shah SM, Khwaja AA, et al. Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study. Ophthalmology. 2010;117(11):2146–51. https://doi.org/10.1016/j.ophtha.2010.08.016.

    Article  PubMed  Google Scholar 

  137. Mitchell P, Bandello F, Schmidt-Erfurth U, et al. The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. Ophthalmology. 2011;118(4):615–25. https://doi.org/10.1016/j.ophtha.2011.01.031.

    Article  Google Scholar 

  138. Korobelnik JF, Do Dv, Schmidt-Erfurth U, et al. Intravitreal aflibercept for diabetic macular edema. Ophthalmology. 2014;121(11):2247–54. https://doi.org/10.1016/j.ophtha.2014.05.006.

    Article  PubMed  Google Scholar 

  139. Heier JS, Korobelnik JF, Brown DM, et al. Intravitreal aflibercept for diabetic macular edema: 148-week results from the VISTA and VIVID studies. In: Ophthalmology. Vol 123. Elsevier Inc.; 2016:2376–2385. https://doi.org/10.1016/j.ophtha.2016.07.032.

  140. Diabetic Retinopathy Clinical Research Network. Comparison of the modified early treatment diabetic retinopathy study and mild macular grid laser photocoagulation strategies for diabetic macular edema. Arch Ophthalmol. 2007;125(4):469–80. https://doi.org/10.1001/archopht.125.4.469.

    Article  PubMed Central  Google Scholar 

  141. Scott IU, Danis RP, Bressler SB, Bressler NM, Browning DJ, Qin H. Effect of focal/grid photocoagulation on visual acuity and retinal thickening in eyes with non-center-involved diabetic macular edema. Retina. 2009;29(5):613–7. https://doi.org/10.1097/IAE.0b013e3181a2c07a.

    Article  PubMed  PubMed Central  Google Scholar 

  142. Takamura Y, Kubo E, Akagi Y. Analysis of the effect of intravitreal bevacizumab injection on diabetic macular edema after cataract surgery. Ophthalmology. 2009;116(6):1151–7. https://doi.org/10.1016/j.ophtha.2009.01.014.

    Article  PubMed  Google Scholar 

  143. Cheema RA, Al-Mubarak MM, Amin YM, Cheema MA. Role of combined cataract surgery and intravitreal bevacizumab injection in preventing progression of diabetic retinopathy. J Cataract Refract Surg. 2009;35(1). https://doi.org/10.1016/j.jcrs.2008.09.019.

  144. Lanzagorta-Aresti A, Palacios0Pozo E, Menenzo-Rozalen JL, Navea-Tejerina A. Prevention of vision loss after cataract surgery in diabetic macular edema with intravitreal bevacizumab: a pilot study. Retina. 2009;29(4). https://doi.org/10.1097/IAE.0b013e31819c6302.

  145. Krepler K, Biowski R, Schrey S, Jandrasits K, Wedrich A. Cataract surgery in patients with diabetic retinopathy: visual outcome, progression of diabetic retinopathy, and incidence of diabetic macular oedema. Graefe’s Arch Clin Exp Ophthalmol. 2002;240(9):735–8. https://doi.org/10.1007/s00417-002-0530-7.

    Article  Google Scholar 

  146. Squirrell D, Bhola R, Bush J, Winder S. A prospective, case controlled study of the natural history of diabetic retinopathy and maculopathy after uncomplicated phacoemulsification cataract surgery in patients with type 2 diabetes. Vol 86.; 2002. http://www.bjophthalmol.com.

  147. Zhao LQ, Cheng JW. A systematic review and meta-Analysis of clinical outcomes of intravitreal anti-VEGF agent treatment immediately after cataract surgery for patients with diabetic retinopathy. J Ophthalmol. 2019;2019. https://doi.org/10.1155/2019/2648267.

  148. • Feng Y, Zhu S, Skiadaresi E, et al. Phacoemulsification cataract surgery with prophylactic intravitreal bevacizumab for patients with coexisting diabetic retinopathy. Retina. 2019;39:1720–1731. http://www.retinajournal.com. A meta-analysis was performed to evaluate the efficacy of intravitreal bevacizumab on patients with diabetic retinopathy undergoing cataract surgery. Analysis of six studies and 283 eyes that met criteria showed improvements in best-corrected visual acuity, central macular thickness, and progression of post-operative diabetic retinopathy and maculopathy compared to controls.

  149. Gross JG, Glassman AR, Jampol LM, et al. Panretinal photocoagulation vs intravitreous ranibizumab for proliferative diabetic retinopathy: a randomized clinical trial. JAMA J Am Med Assoc. 2015;314(20):2137–46. https://doi.org/10.1001/jama.2015.15217.

    Article  CAS  Google Scholar 

  150. Ionides A, Dowler JGF, Hykin PG, Rosen PH, Hamilton Londo AM. Posterior capsule opacification following diabetic extracapular cataract extraction. Eye. 1994;8:535–7.

    Article  Google Scholar 

  151. Ebihara Y, Kato S, Oshika T, Yoshizaki M, Sugita G. Posterior capsule opacification after cataract surgery in patients with diabetes mellitus. J Cataract Refract Surg. 2006;32(7):1184–7. https://doi.org/10.1016/j.jcrs.2006.01.100.

    Article  PubMed  Google Scholar 

  152. Hayashi K, Hayashi H, Nakao F, Hayashi F. Posterior capsule opacification after cataract surgery in patients with diabetes mellitus. Am J Ophthalmol. 2002;134:10–6.

    Article  Google Scholar 

  153. Praveen MR, Vasavada AR, Shah GD, Shah AR, Khamar BM, Dave KH. A prospective evaluation of posterior capsule opacification in eyes with diabetes mellitus: a case-control study. Eye (Basingstoke). 2014;28(6):720–7. https://doi.org/10.1038/eye.2014.60.

    Article  CAS  Google Scholar 

  154. Zaczek A, Zetterstrom C. Posterior capsule opacification after phacoemulsification in patients with diabetes mellitus. J Cataract Refract Surg. 1999;25:233–7.

    Article  CAS  Google Scholar 

  155. Han M, Yu A, Yuan J, Cai X, Ren J. Effect of anterior capsule polish on visual function: a meta-analysis. PLoS ONE. 2019;14(1):e0210205–e0210205. https://doi.org/10.1371/journal.pone.0210205.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Baylor College of Medicine, Houston, TX, USA

    Jonathan A. Go

  2. Cullen Eye Institute, Department of Ophthalmology, Baylor College of Medicine, 1977 Butler Blvd, Houston, TX, 77030, USA

    Christina A. Mamalis & Sumitra S. Khandelwal

Authors
  1. Jonathan A. Go
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christina A. Mamalis
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sumitra S. Khandelwal
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship of this manuscript, take responsibility for the integrity of the work, and have given final approval to the version to be published.

Corresponding author

Correspondence to Sumitra S. Khandelwal.

Ethics declarations

Conflict of Interest

No conflicting relationships exist for any author. SSK is a consultant for Zeiss, Alcon, Bausch & Lomb, Omidria, Ocular Therapeutix, and Dompe.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Microvascular Complications—Retinopathy

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Go, J.A., Mamalis, C.A. & Khandelwal, S.S. Cataract Surgery Considerations for Diabetic Patients. Curr Diab Rep 21, 67 (2021). https://doi.org/10.1007/s11892-021-01418-z

Download citation

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s11892-021-01418-z

Keywords

Search

Navigation